Wegovy dosage chart: labeled doses and schedule
A Wegovy dosage chart starts low and increases every 4 weeks to a maintenance dose. Your prescriber may pause or adjust based on how you tolerate it.
Key facts
- Semaglutide + B12 is $157/month (billed $157 every 4 weeks), charged only after a clinician approves it.
- Answer a few health questions online. A licensed clinician reviews them. If approved, it ships to your door.
- Adults 18 or older. A licensed clinician reviews your health history and decides whether treatment is appropriate for you. Availability depends on the state you live in.

A Wegovy dosage chart is a stepwise schedule that starts at a low dose and increases over time to help your body adjust. This page summarizes the labeled Wegovy (semaglutide) dose schedule for education, not to tell you what dose to take. If you have questions about your own Wegovy dosing or side effects, Vitals Vault offers PocketMD as a place to ask questions using your health history and labs, while dosing decisions stay with your prescribing clinician.
- The Wegovy dosage chart increases every 4 weeks from 0.25 mg to 2.4 mg once weekly.
- The highest dose of Wegovy is 2.4 mg once weekly (maintenance).
- If side effects are hard to tolerate, your prescriber may delay dose increases per the label.
- Missed dose timing rules depend on how close you are to the next scheduled dose.
Wegovy dosage chart: the labeled schedule
Starting dose
Wegovy is started at 0.25 mg once weekly for 4 weeks. This starting dose is meant to help you tolerate treatment and is not intended as a maintenance dose.
Dose increases
After the first 4 weeks, the dose is increased every 4 weeks: 0.5 mg, then 1 mg, then 1.7 mg. Your prescriber may delay a dose increase if you are not tolerating it.
Maintenance dose
The recommended maintenance dose is 2.4 mg once weekly. If 2.4 mg is not tolerated, the label allows a temporary reduction to 1.7 mg once weekly for up to 4 weeks before trying 2.4 mg again.
| Treatment phase | Weeks | Dose (once weekly) |
|---|---|---|
| Start | Weeks 1 to 4 | 0.25 mg |
| Step 2 | Weeks 5 to 8 | 0.5 mg |
| Step 3 | Weeks 9 to 12 | 1 mg |
| Step 4 | Weeks 13 to 16 | 1.7 mg |
| Maintenance | Week 17 and onward | 2.4 mg |
Dose strengths, titration, and missed doses
Wegovy strengths
Wegovy is supplied as single-dose pens in five dose strengths: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg. Your prescription should match the pen strength for your current step.
Do you have to increase?
The labeled schedule increases the dose over time, but your prescriber can delay escalation if you are not tolerating a step. Some people may remain on 1.7 mg maintenance if 2.4 mg cannot be tolerated, based on the label.
Highest and lowest dose
The lowest Wegovy dose is 0.25 mg once weekly as the starting dose. The highest Wegovy dose is 2.4 mg once weekly as the recommended maintenance dose.
| If you miss a dose | What the label says |
|---|---|
| More than 2 days (48 hours) before your next scheduled dose | Take the missed dose as soon as possible. |
| Within 2 days (48 hours) of your next scheduled dose | Skip the missed dose and take your next dose on the regularly scheduled day. |
| You miss 2 or more doses | Resume dosing as scheduled or, if needed, reinitiate and follow the dose escalation schedule to reduce GI symptoms. |
When to talk to your clinician
Severe stomach symptoms
Contact your clinician if nausea, vomiting, or diarrhea is severe, persistent, or leads to dehydration. These symptoms can sometimes contribute to kidney problems, especially if you cannot keep fluids down.
Possible pancreatitis
Get medical care right away for severe abdominal pain that may radiate to your back, with or without vomiting. Pancreatitis has been reported with GLP-1 receptor agonists, including semaglutide.
Gallbladder symptoms
Tell your clinician promptly if you develop upper abdominal pain, fever, jaundice, or clay-colored stools. Gallbladder problems, including gallstones, have been reported in people taking semaglutide for weight management.
Low blood sugar risk
If you use insulin or a sulfonylurea, ask your clinician about hypoglycemia risk and monitoring. The Wegovy label warns that low blood sugar can occur when used with insulin secretagogues or insulin.
Thyroid or neck symptoms
Report a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. Wegovy has a boxed warning about thyroid C-cell tumors seen in rodents, and it is contraindicated with certain thyroid cancer histories.
Practical pro tips for staying on schedule
Pick a consistent day
Use a weekly reminder so doses stay evenly spaced, as the label intends.
Expect GI effects early
Nausea and other GI symptoms are common during titration. Tell your clinician if they limit eating or hydration.
Ask before escalating
If you are struggling at a step, ask whether to delay escalation rather than pushing through.
Know your pen strength
Confirm the pen strength matches your current step to avoid mix-ups.
Injection questions are label-based
Your pharmacist or clinician should show you how to use the pen, and the Instructions for Use cover the steps.
Frequently Asked Questions
What is the highest dose of Wegovy?
The highest dose of Wegovy in the FDA-approved schedule is 2.4 mg once weekly. This is the recommended maintenance dose after completing the stepwise dose escalation.
What are the doses of Wegovy?
Wegovy comes in five dose strengths: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg. The labeled schedule starts at 0.25 mg once weekly and increases every 4 weeks to a maintenance dose.
What is the lowest dose of Wegovy?
The lowest Wegovy dose is 0.25 mg once weekly. The label uses this as the starting dose for the first 4 weeks to improve tolerability.
Do you have to increase Wegovy dose?
The FDA label uses a stepwise increase every 4 weeks, but your prescriber may delay an increase if you are not tolerating a dose. Some people may use 1.7 mg as a maintenance dose if 2.4 mg cannot be tolerated, per the label.
What is the Wegovy dosage chart schedule, week by week?
The labeled Wegovy dosage chart is 0.25 mg weekly for weeks 1 to 4, then 0.5 mg (weeks 5 to 8), 1 mg (weeks 9 to 12), 1.7 mg (weeks 13 to 16), and 2.4 mg weekly from week 17 onward. Your clinician may adjust timing based on tolerability.